The historic rise of Viagra has consistently remained a example of pharmaceutical success, however its legacy within the broader sector now raises questions about potential yields . Copycat versions are diminishing exclusivity , prompting concerns that betting on companies closely tied to Viagra's former influence could be a problematic strategy… Read More